Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious risks of blood transfusion.

Lynne Uhl1

  • 1Yamins 309, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. luhl@caregroup.harvard.edu

Current Hematology Reports
|August 7, 2003
PubMed
Summary

Blood safety has dramatically improved, with HIV transmission risk now 1 in 1 million. New research focuses on preventing transfusion-transmitted bacteria, parasites, and prions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial.

Transfusion·2025
Same author

Determinants and clinical impact of time to plasma exchange in patients with immune thrombotic thrombocytopenic purpura.

Transfusion·2025
Same author

Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia.

American heart journal·2025
Same author

Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components.

Blood advances·2024
Same author

How do we use the National Healthcare Safety Network for Hemovigilance in Massachusetts?

Transfusion·2023

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Transmission
  • Public Health

Background:

  • Public demand for a zero-risk blood supply intensified after HIV transmission events.
  • Significant advancements in donor selection, testing, and processing have reduced viral risks.

Purpose of the Study:

  • To review the impact of safety measures on transfusion-transmitted viral infections.
  • To address emerging concerns about non-viral infectious agents in transfused blood.

Main Methods:

  • Analysis of changes in blood donor screening and processing protocols.
  • Review of epidemiological data on transfusion-transmitted infections.
  • Examination of ongoing research into novel infectious agents.

Main Results:

  • Human Immunodeficiency Virus (HIV) transmission risk is now approximately 1 in 1 million units.
  • Risks associated with other transfusion-transmitted viral infections have also been substantially reduced.

Conclusions:

  • Current blood safety strategies have markedly decreased viral transmission risks.
  • Further research is critical to identify and mitigate risks from bacteria, parasites, and prions in blood transfusions.

Related Experiment Videos